REPORT ID 2169

Global Prostate Cancer Medicine Market Professional Survey Report 2017

Publish Date
7-Dec-17
Pages
103
Format
Electronic (PDF)

This report studies Prostate Cancer Medicine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    AstraZeneca plc
    Active Biotech
    Bristol Myers-Squibb
    Teva Pharmaceuticals Industries Ltd.
    Johnson & Johnson
    Pfizer Inc.
    Bayer AG
    Abbott Laboratories
    Astellas Pharma Inc.
    Roche Holding AG

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Hormonal Therapy Drugs
    Chemotherapy Drugs
    Immunotherapy Drugs
    Target Therapy Drugs

By Application, the market can be split into
    Hospital
    Pharmacy
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Prostate Cancer Medicine Market Professional Survey Report 2017
1 Industry Overview of Prostate Cancer Medicine
    1.1 Definition and Specifications of Prostate Cancer Medicine
        1.1.1 Definition of Prostate Cancer Medicine
        1.1.2 Specifications of Prostate Cancer Medicine
    1.2 Classification of Prostate Cancer Medicine
        1.2.1 Hormonal Therapy Drugs
        1.2.2 Chemotherapy Drugs
        1.2.3 Immunotherapy Drugs
        1.2.4 Target Therapy Drugs
    1.3 Applications of Prostate Cancer Medicine
        1.3.1 Hospital
        1.3.2 Pharmacy
        1.3.3 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Prostate Cancer Medicine
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Prostate Cancer Medicine
    2.3 Manufacturing Process Analysis of Prostate Cancer Medicine
    2.4 Industry Chain Structure of Prostate Cancer Medicine

3 Technical Data and Manufacturing Plants Analysis of Prostate Cancer Medicine
    3.1 Capacity and Commercial Production Date of Global Prostate Cancer Medicine Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Prostate Cancer Medicine Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Prostate Cancer Medicine Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Prostate Cancer Medicine Major Manufacturers in 2016

4 Global Prostate Cancer Medicine Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Prostate Cancer Medicine Capacity and Growth Rate Analysis
        4.2.2 2016 Prostate Cancer Medicine Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Prostate Cancer Medicine Sales and Growth Rate Analysis
        4.3.2 2016 Prostate Cancer Medicine Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Prostate Cancer Medicine Sales Price
        4.4.2 2016 Prostate Cancer Medicine Sales Price Analysis (Company Segment)

5 Prostate Cancer Medicine Regional Market Analysis
    5.1 North America Prostate Cancer Medicine Market Analysis
        5.1.1 North America Prostate Cancer Medicine Market Overview
        5.1.2 North America 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Prostate Cancer Medicine Sales Price Analysis
        5.1.4 North America 2016 Prostate Cancer Medicine Market Share Analysis
    5.2 China Prostate Cancer Medicine Market Analysis
        5.2.1 China Prostate Cancer Medicine Market Overview
        5.2.2 China 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Prostate Cancer Medicine Sales Price Analysis
        5.2.4 China 2016 Prostate Cancer Medicine Market Share Analysis
    5.3 Europe Prostate Cancer Medicine Market Analysis
        5.3.1 Europe Prostate Cancer Medicine Market Overview
        5.3.2 Europe 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Prostate Cancer Medicine Sales Price Analysis
        5.3.4 Europe 2016 Prostate Cancer Medicine Market Share Analysis
    5.4 Southeast Asia Prostate Cancer Medicine Market Analysis
        5.4.1 Southeast Asia Prostate Cancer Medicine Market Overview
        5.4.2 Southeast Asia 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Prostate Cancer Medicine Sales Price Analysis
        5.4.4 Southeast Asia 2016 Prostate Cancer Medicine Market Share Analysis
    5.5 Japan Prostate Cancer Medicine Market Analysis
        5.5.1 Japan Prostate Cancer Medicine Market Overview
        5.5.2 Japan 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Prostate Cancer Medicine Sales Price Analysis
        5.5.4 Japan 2016 Prostate Cancer Medicine Market Share Analysis
    5.6 India Prostate Cancer Medicine Market Analysis
        5.6.1 India Prostate Cancer Medicine Market Overview
        5.6.2 India 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Prostate Cancer Medicine Sales Price Analysis
        5.6.4 India 2016 Prostate Cancer Medicine Market Share Analysis

6 Global 2012-2017E Prostate Cancer Medicine Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Prostate Cancer Medicine Sales by Type
    6.2 Different Types of Prostate Cancer Medicine Product Interview Price Analysis
    6.3 Different Types of Prostate Cancer Medicine Product Driving Factors Analysis
        6.3.1 Hormonal Therapy Drugs of Prostate Cancer Medicine Growth Driving Factor Analysis
        6.3.2 Chemotherapy Drugs of Prostate Cancer Medicine Growth Driving Factor Analysis
        6.3.3 Immunotherapy Drugs of Prostate Cancer Medicine Growth Driving Factor Analysis
        6.3.4 Target Therapy Drugs of Prostate Cancer Medicine Growth Driving Factor Analysis

7 Global 2012-2017E Prostate Cancer Medicine Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Prostate Cancer Medicine Consumption by Application
    7.2 Different Application of Prostate Cancer Medicine Product Interview Price Analysis
    7.3 Different Application of Prostate Cancer Medicine Product Driving Factors Analysis
        7.3.1 Hospital of Prostate Cancer Medicine Growth Driving Factor Analysis
        7.3.2 Pharmacy of Prostate Cancer Medicine Growth Driving Factor Analysis
        7.3.3 Others of Prostate Cancer Medicine Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Prostate Cancer Medicine
    8.1 AstraZeneca plc
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 AstraZeneca plc 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 AstraZeneca plc 2016 Prostate Cancer Medicine Business Region Distribution Analysis
    8.2 Active Biotech
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Active Biotech 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Active Biotech 2016 Prostate Cancer Medicine Business Region Distribution Analysis
    8.3 Bristol Myers-Squibb
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Bristol Myers-Squibb 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Bristol Myers-Squibb 2016 Prostate Cancer Medicine Business Region Distribution Analysis
    8.4 Teva Pharmaceuticals Industries Ltd.
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Teva Pharmaceuticals Industries Ltd. 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Teva Pharmaceuticals Industries Ltd. 2016 Prostate Cancer Medicine Business Region Distribution Analysis
    8.5 Johnson & Johnson
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Johnson & Johnson 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Johnson & Johnson 2016 Prostate Cancer Medicine Business Region Distribution Analysis
    8.6 Pfizer Inc.
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Pfizer Inc. 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Pfizer Inc. 2016 Prostate Cancer Medicine Business Region Distribution Analysis
    8.7 Bayer AG
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Bayer AG 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Bayer AG 2016 Prostate Cancer Medicine Business Region Distribution Analysis
    8.8 Abbott Laboratories
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Abbott Laboratories 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Abbott Laboratories 2016 Prostate Cancer Medicine Business Region Distribution Analysis
    8.9 Astellas Pharma Inc.
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Astellas Pharma Inc. 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Astellas Pharma Inc. 2016 Prostate Cancer Medicine Business Region Distribution Analysis
    8.10 Roche Holding AG
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Roche Holding AG 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Roche Holding AG 2016 Prostate Cancer Medicine Business Region Distribution Analysis

9 Development Trend of Analysis of Prostate Cancer Medicine Market
    9.1 Global Prostate Cancer Medicine Market Trend Analysis
        9.1.1 Global 2017-2022 Prostate Cancer Medicine Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Prostate Cancer Medicine Sales Price Forecast
    9.2 Prostate Cancer Medicine Regional Market Trend
        9.2.1 North America 2017-2022 Prostate Cancer Medicine Consumption Forecast
        9.2.2 China 2017-2022 Prostate Cancer Medicine Consumption Forecast
        9.2.3 Europe 2017-2022 Prostate Cancer Medicine Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Prostate Cancer Medicine Consumption Forecast
        9.2.5 Japan 2017-2022 Prostate Cancer Medicine Consumption Forecast
        9.2.6 India 2017-2022 Prostate Cancer Medicine Consumption Forecast
    9.3 Prostate Cancer Medicine Market Trend (Product Type)
    9.4 Prostate Cancer Medicine Market Trend (Application)

10 Prostate Cancer Medicine Marketing Type Analysis
    10.1 Prostate Cancer Medicine Regional Marketing Type Analysis
    10.2 Prostate Cancer Medicine International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Prostate Cancer Medicine by Region
    10.4 Prostate Cancer Medicine Supply Chain Analysis

11 Consumers Analysis of Prostate Cancer Medicine
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Prostate Cancer Medicine Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source